What type of ureteroneocystostomy repair is indicated for a pediatric patient with ureterovesical obstruction and a markedly dilated ureter?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Ureteroneocystostomy Repair for Pediatric Ureterovesical Obstruction with Dilated Ureter

For a pediatric patient with ureterovesical obstruction and a markedly dilated ureter, perform an extravesical ureteral reimplantation (such as Lich-Gregoir or Politano-Leadbetter technique) with ureteral tapering when the ureter diameter is significantly enlarged.

Surgical Approach Selection

The choice between intravesical and extravesical techniques depends on the degree of ureteral dilation and surgical expertise:

Extravesical Techniques (Preferred for Dilated Ureters)

  • Extravesical reimplantation preserves the natural anatomical course of the ureter and allows easier correction of ureteral length and width 1
  • The Politano-Leadbetter technique maintains the physiologic ureteral trajectory without changing its direction, though operative time is slightly longer than Cohen technique 2
  • Recent evidence shows that laparoscopic Lich-Gregoir (LLG) and transvesicoscopic Politano-Leadbetter (TPL) approaches yield comparable outcomes in infants and toddlers with primary obstructive megaureter 3
  • Robot-assisted extravesical ureteral reimplantation (REVUR) demonstrates excellent outcomes for complex obstructed megaureter, with 100% success rates and improved hydroureteronephrosis at median 34.5-month follow-up 4

Intravesical Techniques

  • Transvesicoscopic Cohen reimplantation has shorter operative times (128 vs 143 minutes) but shows slightly less improvement in hydronephrosis at 6 months compared to Politano-Leadbetter 2
  • Both techniques achieve similar success rates (97.1% vs 96.6%) 2

Ureteral Tapering

Ureteral tapering is required in approximately 44% of complex obstructive megaureter cases 4. The decision to taper should be made based on:

  • Degree of ureteral dilation on preoperative imaging
  • Intraoperative assessment of ureteral caliber
  • Ability to create an adequate submucosal tunnel without excessive bulk

Excisional tailoring can be performed intracorporeally during laparoscopic or robotic procedures, using a double-J stent to calibrate the appropriate ureteral diameter 5

Minimally Invasive vs Open Approach

Modern minimally invasive techniques offer significant advantages:

  • Robotic and laparoscopic approaches are safe and effective with low complication rates (10-14.3%), no conversions to open surgery, and favorable long-term outcomes 3, 4
  • Median operative time ranges from 137-220 minutes depending on complexity 3, 4
  • Hospital stay averages 3-4 days with rapid return to oral intake 3
  • All approaches show preserved differential renal function and improved drainage on follow-up imaging 3, 4

Critical Diagnostic Pitfall

Always rule out dual-level obstruction (concomitant UPJ and UVJ obstruction) before proceeding with isolated UVJ repair. Standard ultrasonography and diuretic renography frequently miss proximal pathology 6. Consider:

  • Retrograde or antegrade pyelography when standard imaging is inconclusive
  • Intraoperative assessment of retrograde stent passage
  • If dual obstruction is confirmed, staged repair beginning with pyeloplasty is most reliable, as proximal correction often improves distal drainage 6

Postoperative Management

  • Double-J stent removal at 4-6 weeks postoperatively 4
  • Monitor for low-grade vesicoureteral reflux (occurs in <10% of cases, typically resolves with conservative management) 3
  • Follow-up imaging to confirm resolution of hydroureteronephrosis and preserved renal function 4, 2

References

Related Questions

A 9‑mm calculus in the proximal left ureter causing moderate left‑sided hydronephrosis—should the patient be admitted?
In a 9‑year‑old boy with bilateral hydronephrosis, a partially obstructed left kidney with preserved function, who is asymptomatic after laparoscopic left pyeloplasty for crossing vessels with a double‑J (DJ) ureteral stent placed, when should the double‑J stent be removed?
What is the diagnosis and appropriate treatment, including medication dosages, for an 18‑year‑old male with sudden severe hypogastric pain, hematuria, bilateral 3‑mm renal calculi (non‑obstructive) and mild left hydroureteronephrosis, who is vomiting possibly due to tramadol?
In a 37-year-old male with severe right flank pain unrelieved by analgesics, urinalysis positive for blood and negative for nitrite, elevated serum creatinine, and imaging showing an 8 mm ureteral stone with hydronephrosis, what is the most appropriate immediate management?
In an elderly female admitted from the emergency department with a history of Enterococcus infection, rising serum creatinine and CT evidence of severe hydronephrosis, should urgent urology involvement for ureteral stent placement be pursued?
How should a laceration above the eyebrow be sutured to minimize scarring?
In pediatric patients with confirmed autosomal dominant polycystic kidney disease (ADPKD) and nocturnal enuresis, what special considerations, contraindications, or treatment modifications are recommended?
What is the appropriate management for a 21-year-old female with a two‑month history of recurrent intraoral vesicular lesions that rupture and a lifelong history of similar episodes?
Can low-dose aspirin be combined with etoricoxib?
For a 67-year-old female with type 1 diabetes, weight 61 kg, normal renal function, taking olanzapine (Zyprexa), buspirone (Buspar), hydroxyzine (Atarax), quetiapine (Seroquel), sertraline (Zoloft), and trazodone, currently on insulin glargine (Lantus) 8 U daily with an insulin‑to‑carbohydrate ratio of 1 U per 12 g carbs and an insulin sensitivity factor of 1 U per 60 mg/dL, and experiencing hyperglycemia (glucose 314–354 mg/dL) but prone to hypoglycemia if aggressive, what should her insulin glargine dose, insulin‑to‑carbohydrate ratio, and insulin sensitivity factor be?
What is the differential diagnosis for dyspnea with hypoxemia and a right-sided pleural effusion that shows lymphocytic predominance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.